| Literature DB >> 31787360 |
Donatella Bagetta1, Annalisa Maruca1, Antonio Lupia1, Francesco Mesiti1, Raffaella Catalano1, Isabella Romeo2, Federica Moraca3, Francesca Alessandra Ambrosio4, Giosuè Costa1, Anna Artese1, Francesco Ortuso1, Stefano Alcaro1, Roberta Rocca5.
Abstract
Alteration of nutritional habits play an essential role on the risk of developing Metabolic Syndrome (MetS). Several epidemiological studies have shown that assuming diets rich of foods included in the Mediterranean diet (MetDiet) pattern like, such as olive oil, nuts, fruit, fiber, vegetables, wine and grain cereals has protective effects on the different risk factors characterizing the MetS. The beneficial effects of the MetDiet in the MetS are mainly due to the antioxidant and anti-inflammatory properties of the most abundant phytochemical components of such foods as polyphenols like resveratrol and oleuropein, allyl sulfides, ellagic acid, mono- and poly-unsaturated fatty acids (MUFA and PUFA), tocopherols and flavonoids like quercetin, which have shown positive results in the prevention of cardiovascular diseases (CVDs), with related risk factors, like hypertension, hypercholesterolemia and obesity. In this review, we highlighted the multi-target activities of the bioactive components contained in some foods typical of the Mediterranean area like olive oil, onion, liquorice, rosemary, oregano, hazelnut, pistachio, "Melannurca" apple, red wine, hot pepper, Citrus sp. fruits, saffron and garlic, with particular focus on their impact on health outcomes in relation to MetS main key factors, such as insulin resistance (IR) and type 2 diabetes mellitus (T2DM), endothelial dysfunctions, inflammatory response, oxidative stress and dyslipidaemic and hypercholesterolemic effects.Entities:
Keywords: Anti-inflammatory; Anti-oxidant; Mediterranean diet (MedDiet); Metabolic syndrome (MetS); Multi-target; Polypharmacology; Polyphenols; Prevention
Mesh:
Substances:
Year: 2019 PMID: 31787360 DOI: 10.1016/j.ejmech.2019.111903
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514